Skip to content

A Clinical and Mechanistic Study on the Healing of Postoperative Wounds in High-Complexity Anal Fistula Surgery Using Lianfu San

A Clinical and Mechanistic Study on the Healing of Postoperative Wounds in High-Positioned Complex Anal Fistula Using Lianfu San

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2026000823
Enrollment
Unknown
Registered
2026-03-30
Start date
2026-04-01
Completion date
Unknown
Last updated
2026-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anal fistula

Interventions

Experimental Group:Skin-contracting powder medication change method
Control Group:Iodophor dressing change

Sponsors

Nanjing City Hospital of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: (1) Must meet the diagnostic criteria for high-complexity anal fistula; (2) Age between 18 and 60 years old, with no gender restrictions; (3) Preoperative auxiliary examination results will not impact the treatment of this disease; (4) Establish an intravenous line before surgery; (5) Be informed about the study content, sign the informed consent form, and be willing to accept long-term follow-up after surgery.

Exclusion criteria

Exclusion criteria: (1) Patients with hematological disorders or diseases of the heart, brain, or kidneys; those who have recently taken immunosuppressants or anticoagulants; (2) Patients with organic conditions such as tumors or inflammatory bowel disease; (3) Patients with anal fistulas caused by systemic infections such as hematological or tuberculosis-related infections; (4) Patients who are pregnant or breastfeeding; (5) Patients with allergies to relevant medications, those with allergic constitutions, or those with a tendency to develop keloids; (6) Patients with mental disorders or those who have taken psychotropic medications in the past three months.

Design outcomes

Primary

MeasureTime frame
Tumor Necrosis Factor alpha;Interleukin-6;Vascular Endothelial Growth Factor;Epidermal Growth Factor;Postoperative wound area;Wound Area Reduction Rate;Wound healing time;Hematoxylin and Eosin staining;Masson staining;

Secondary

MeasureTime frame
Granulation Morphology;Granulation Tissue Color Rating;Wound Exudate Scoring;Wound pain score;Anal Incontinence Assessment;Recurrence rate;

Countries

China

Contacts

Public ContactKang Ding

Nanjing City Hospital of Traditional Chinese Medicine

51422503@qq.com18951755243

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: May 1, 2026